Gapping down
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- IBTA -41%, TNDM -16.7%, WPP -15.6%, TDOC -13.2%, EFXT -12.4%, TFX -11.3%, FA -11.1%, HAFN -10.8%, SG -10.3%, AAON -10.2%, PSTG -8.4% (also authorizes up to $250 mln in additional buybacks), EBAY -7.6%, VTRS -7.5%, VERX -6.2%, DQ -5.4%, PLTK -5.4%, AAOI -4.9%, BYND -4.9% (also announces further restructuring initiatives, including workforce reduction), ERII -4.6% (also names new CTO, announces new $30 mln buyback auth), AMBP -4.5%, NMFC -4.3%, PBR -4.3%, AI -4.1%, ECPG -4%, BBWI -4%, SHC -4%, BAK -3.9%, FE -3.6%, HNST -3.2%, CRM -3.2%, FWRD -3.2%, IONQ -3.1% (also names new CEO; also to acquire ID Quantique and enters into quantum strategic partnership with SK Telecom; also announces $500 mln ATM stock offering; also files mixed shelf securities offering), RVMD -3.1%, TKO -3%, FTAI -2.8%, HLN -2.8%, DCO -2.8%, BWLP -2.7%, XRAY -2.7%, MDXG -2.6%, KRP -2.6%, MAC -2.6%, MGNI -2.4%, KTOS -2.4% (also announces 50/50 partnership with RAFAEL Advanced Defense for solid rocket motors), AMWD -2.4%, GLNG -2.4%, GEO -2.2%, OVV -2.1%, BBSI -2%, A -1.8%, CRGY -1.8%, PENN -1.8%, SRPT -1.7%, KNTK -1.7%, MTTR -1.7%, ACAD -1.7%, NVCR -1.6%, SJW -1.5%, PARA -1.4%, FSK -1.3%, INVA -1.2%, CDNA -1.1%, EXE -1%, AIN -1% (also new $250 mln share repurchase program), VRNA -1%,
Other news:
- MRNA -4.7% (Trump administration contemplates pulling bird flu vaccine funding, according to Bloomberg)
- MFH -3.3% (Highlights Growing Institutional Ownership, Reinforcing Growth Strategy)
- KDP -3.1% (announces the pricing of its previously-announced registered public offering of 73,000,000 shares through a secondary offering by a subsidiary of JAB Holding Company s.a.r.l., at a price to the public of $32.80/share)
- RACE -2.9% (participated as a purchaser in Exor's accelerated bookbuild offering)
- SMCI -1.5% (now complies with Nasdaq; matter with SEC is now closed)
Analyst comments:
- STZ -1.5% (downgraded to Equal-Weight from Overweight at Morgan Stanley)